학술논문
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Document Type
Artikel
Author
Sparks, JA; Wallace, ZS; Seet, AM; Gianfrancesco, MA; Izadi, Z; Hyrich, KL; Strangfeld, A; Gossec, L; Carmona, L; Mateus, EF; Lawson-Tovey, S; Trupin, L; Rush, S; Katz, P; Schmajuk, G; Jacobsohn, L; Wise, L; Gilbert, EL; Duarte-Garcia, A; Valenzuela-Almada, MO; Pons-Estel, GJ; Isnardi, CA; Berbotto, GA; Hsu, TYT; D'Silva, KM; Patel, NJ; Kearsley-Fleet, L; Schafer, M; Ribeiro, SLE; Al Emadi, S; Tidblad, L; Scire, CA; Raffeiner, B; Thomas, T; Flipo, RM; Avouac, J; Seror, R; Bernardes, M; Cunha, MM; Hasseli, R; Schulze-Koops, H; Muller-Ladner, U; Specker, C; de Souza, VA; da Mota, LMH; Gomides, APM; Dieude, P; Nikiphorou, E; Kronzer, VL; Singh, N; Ugarte-Gil, MF; Wallace, B; Akpabio, A; Thomas, R; Bhana, S; Costello, W; Grainger, R; Hausmann, JS; Liew, JW; Sirotich, E; Sufka, P; Robinson, PC; Machado, PM; Yazdany, J
Source
Annals of the rheumatic diseases. 80(9):1137-1146
Subject
Language
English
English
English
ISSN
1468-2060